Upstream Bio

Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases
Yahoo/Businesswire
Thu, 06/8/23 - 10:00 am
Upstream Bio
funding
inflammation
allergies
UPB-101
The retrenchment begins for venture funding
EP Vantage
Fri, 07/8/22 - 10:36 am
funding
venture capital
Upstream Bio
Frontera Therapeutics
Aspen Neuro
Tessa Therapeutics
ReCode Therapeutics
Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases
BioSpace
Thu, 06/2/22 - 10:35 am
Upstream Bio
funding
asthma
allergies